Form 4: Celularity Director Peter Diamandis Acquires Shares

Celularity Inc. Director Peter Diamandis reported the acquisition of 67,416 shares of Class A Common Stock through the vesting of restricted stock units.

Summary

• Peter Diamandis, a Director of Celularity Inc. (CELU), acquired 67,416 shares of Class A Common Stock.
• The acquisition occurred on December 19, 2025, and was reported on December 22, 2025.
• These shares represent Restricted Stock Units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan.
• Each RSU represents a right to receive one share of the Issuer's Class A common stock, and the RSUs vested on December 19, 2025.
• The transaction price for these shares was $0.00, indicating a grant or vesting event rather than a purchase.
• Following this transaction, Peter Diamandis directly beneficially owns 248,765 shares of Class A Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction (vesting of RSUs) which is generally neutral but can be seen as slightly positive due to increased insider ownership and the use of a 10b5-1 plan for transparency.

Positives

• The vesting of Restricted Stock Units (RSUs) for a director indicates continued alignment of management interests with shareholder value.
• The transaction was conducted under a Rule 10b5-1(c) plan, demonstrating a pre-arranged and transparent approach to insider stock transactions.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, specifically the vesting of equity compensation for a director. It does not provide broader industry context or competitive analysis.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may signal confidence in the company's long-term prospects, aligning management's interests with those of shareholders.

Key Dates

Keywords

Celularity, CELU, Peter Diamandis, Insider Transaction, Form 4, Restricted Stock Units, RSU, Equity Incentive Plan, Stock Acquisition, Director